Form D — Bonum Therapeutics, Inc.
0001898714-26-000001 · filed 2026-04-17
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $32,301,381
- Total sold
- $26,907,396
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Bonum Therapeutics, Inc.
- CIK
- 1898714
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1150 EASTLAKE AVENUE E
SEATTLE, WA 98109 - Phone
- 206-888-8485
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
John Mulligan · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
John McKearn · DirectorSeattle, WA Find on LinkedIn ↗
-
Monique Schiersing · DirectorSeattle, WA Find on LinkedIn ↗
-
Nicholas Walrod · DirectorSeattle, WA Find on LinkedIn ↗
-
Karl Handelsman · DirectorSeattle, WA Find on LinkedIn ↗
-
Diane Hollenbaugh · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Neela Patel · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Mitchell Mutz · DirectorSeattle, WA Find on LinkedIn ↗
-
Samuel Bjork · DirectorSeattle, WA Find on LinkedIn ↗
-
Gaurav Aggarwal · DirectorSeattle, WA Find on LinkedIn ↗
-
Samuel Blackman · DirectorSeattle, WA Find on LinkedIn ↗
View original on SEC EDGAR.